TD Cowen Maintains Buy on Amgen, Raises Price Target to $383
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Yaron Weber maintains a Buy rating on Amgen and raises the price target from $381 to $383.
October 21, 2024 | 5:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Yaron Weber has reiterated a Buy rating for Amgen and slightly increased the price target from $381 to $383, indicating a positive outlook.
The Buy rating and increased price target suggest confidence in Amgen's future performance, likely leading to a positive short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100